ID   SFT-T1
AC   CVCL_C6JI
DR   Wikidata; Q116050499
RX   PubMed=36428694;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 4 fused to STAT6 exon 2 (PubMed=36428694).
CC   Miscellaneous: STR profile from personal communication of Baier, Dina.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D21S11: 28,31
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 19,23
ST   Penta D: 10,13
ST   Penta E: 7,14
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4457; Pleural solitary fibrous tumor
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=36428694; DOI=10.3390/cancers14225602; PMCID=PMC9688590;
RA   Ghanim B., Baier D., Pirker C., Mullauer L., Sinn K., Lang G.,
RA   Hoetzenecker K., Berger W.;
RT   "Trabectedin is active against two novel, patient-derived solitary
RT   fibrous pleural tumor cell lines and synergizes with ponatinib.";
RL   Cancers (Basel) 14:5602.1-5602.16(2022).
//